The antibody zalutumumab inhibits epidermal growth factor receptor signaling by limiting intra- and intermolecular flexibility.

Lammerts van Bueren, J.J.; Bleeker, W.K.; Brännström, A.; Von Euler, A.; Jansson, M.; Peipp, M.; Schneider-Merck, T.; Valerius, T.; van de Winkel, J.G.J.; Parren, P.W.H.I.

The antibody zalutumumab inhibits epidermal growth factor receptor signaling by limiting intra- and intermolecular flexibility.

DSpace/Manakin Repository

The antibody zalutumumab inhibits epidermal growth factor receptor signaling by limiting intra- and intermolecular flexibility.

Lammerts van Bueren, J.J.; Bleeker, W.K.; Brännström, A.; Von Euler, A.; Jansson, M.; Peipp, M.; Schneider-Merck, T.; Valerius, T.; van de Winkel, J.G.J.; Parren, P.W.H.I.

(2008) Proceedings of the National Academy of Sciences of the United States of America, volume 105, issue 16, pp. 6109 - 6114

(Article)

Download/Full Text

Open Access version via Utrecht University Repository

Unknown

ISSN: 0027-8424

Publisher: National Academy of Sciences

(Peer reviewed)

See more statistics about this item